A new study by scientists at Washington University School of Medicine in St. Louis and Lund University in Sweden found that a new Alzheimer’s blood test could lead to more personalized care.
The test detects the disease and the degree of the condition, according to a release. Additionally, it can decipher “whether a person’s symptoms are likely due to Alzheimer’s versus some other cause.”
The study, published in Nature Medicine, “found that levels of a protein called MTBR-tau243 in the blood accurately reflect the amount of toxic accumulation of tau aggregates in the brain and correlate with the severity of Alzheimer’s disease.” According to the research, detection was 92% accurate.
